insights_auto
Why is ARGX down 4,09%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
727,60 €
arrow_downward
-4,09%(-31,00) 1D
16-окт., 17:39:35 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
759,20 €
High
761,80 €
Low
727,60 €
Mkt. cap
48,36 млд
Avg. vol.
86,90 миң
Volume
96,25 миң
P/E ratio
30,95
52-wk high
925,00 €
52-wk low
568,40 €
EPS
23,51 €
Shares outstanding
35,93 млн
No. of employees
2 миң
Open
759,20 €
High
761,80 €
Low
727,60 €
Mkt. cap
48,36 млд
Avg. vol.
86,90 миң
Volume
96,25 миң
P/E ratio
30,95
52-wk high
925,00 €
52-wk low
568,40 €
EPS
23,51 €
Shares outstanding
35,93 млн
No. of employees
2 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
1 күн мурун
argenx reports trial results: what it means for argenx stock
TipRanks
·
1 күн мурун
Argenx Stock Stumbles As Trial Failure Haunts Rally
ad-hoc-news.de
·
2 күн мурун
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
2 күн мурун
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE